These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 981321)
41. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF. Godwin-Austen RB J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):219-23. PubMed ID: 5571307 [TBL] [Abstract][Full Text] [Related]
43. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. Garver DL; Bissette G; Yao JK; Nemeroff CB Am J Psychiatry; 1991 Apr; 148(4):484-8. PubMed ID: 2006695 [TBL] [Abstract][Full Text] [Related]
44. 5-HIAA and HVA in cerebrospinal fluid during delirium acutum. Johansson B; Roos BE; Wålinder J N Engl J Med; 1972 May; 286(21):1160-1. PubMed ID: 5019651 [No Abstract] [Full Text] [Related]
45. The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia. Cooper SJ; Leahey W; Liddle J; King DJ Schizophr Res; 1990; 3(4):261-7. PubMed ID: 1703780 [TBL] [Abstract][Full Text] [Related]
46. High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study. Zarifian E; Scatton B; Bianchetti G; Cuche H; Loo H; Morselli PL Arch Gen Psychiatry; 1982 Feb; 39(2):212-5. PubMed ID: 7065833 [TBL] [Abstract][Full Text] [Related]
47. Cinnarizine-induced parkinsonism in primates. García Ruiz PJ; Mena MA; Peñafiel N; De Yébenes JG Clin Neuropharmacol; 1992 Apr; 15(2):152-4. PubMed ID: 1375537 [TBL] [Abstract][Full Text] [Related]
48. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Sedvall G; Fyrö B; Nybäck H; Wiesel FA; Wode-Helgodt B J Psychiatr Res; 1974; 11():75-80. PubMed ID: 4461807 [No Abstract] [Full Text] [Related]
49. "Tolerance" to neuroleptic-induced CSF HVA rise in schizophrenic patients in relation to clinical response. Joseph MH; Waddington JL Psychiatry Res; 1982 Aug; 7(1):133. PubMed ID: 6127745 [No Abstract] [Full Text] [Related]
50. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics. Van Praag HM; Korf J Am J Psychiatry; 1976 Oct; 133(10):1171-7. PubMed ID: 970488 [TBL] [Abstract][Full Text] [Related]
51. Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women. Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G Arch Psychiatr Nervenkr (1970); 1979; 227(3):181-92. PubMed ID: 94992 [No Abstract] [Full Text] [Related]
53. Effects of debrisoquin on CSF and plasma HVA concentrations in man. Maas JW; Contreras SA; Bowden CL; Weintraub SE Life Sci; 1985 Jun; 36(22):2163-70. PubMed ID: 3999921 [TBL] [Abstract][Full Text] [Related]
54. Treatment and prognosis of hemiballismus. Klawans HL; Moses H; Nausieda PA; Bergen D; Weiner WJ N Engl J Med; 1976 Dec; 295(24):1348-50. PubMed ID: 980081 [TBL] [Abstract][Full Text] [Related]
56. Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol. Moleman P; Janzen G; von Bargen BA; Kappers EJ; Pepplinkhuizen L; Schmitz PI Am J Psychiatry; 1986 Feb; 143(2):232-4. PubMed ID: 3946663 [TBL] [Abstract][Full Text] [Related]